Updated
EvolusEOLS · Healthcare
$6.80+0.15%
Market cap$450M
IndustryDrug Manufacturers - Specialty & Generic
Evolus (EOLS) Superinvestor holders
6 of the superinvestors we track hold Evolus (EOLS) in their latest 13F filings, $55M in total.
Summary
The largest holder is Wilmot Harkey (Nantahala Capital Management), with $39M, 2.4% of the portfolio.
In their latest quarter: 2 opened a new position, 1 added, 3 trimmed.
Who holds it
Each investor's latest 13F filing, largest stake first. What a 13F shows.
| Investor | Last change | Shares | Value | % of portfolio | Filed for |
|---|---|---|---|---|---|
| Wilmot Harkey Nantahala Capital Management |
Trimmed | 5,602,021 | $39M | 2.4% | Q2 2026 |
| Steve Cohen Point72 Asset Management |
New position | 1,508,518 | $10M | 0.0% | Q2 2026 |
| David Shaw D. E. Shaw & Co. |
Trimmed | 336,901 | $2M | 0.0% | Q2 2026 |
| Jim Simons Renaissance Technologies |
Trimmed | 302,569 | $2M | 0.0% | Q2 2026 |
| Cliff Asness AQR Capital Management |
Added | 97,563 | $677,087 | 0.0% | Q2 2026 |
| Paul Tudor Jones Tudor Investment Corp |
New position | 31,547 | $218,936 | 0.0% | Q2 2026 |
Holders by quarter
| Quarter | Superinvestors holding it |
|---|---|
| Q2 2026 | 6 |
| Q1 2026 | 6 |
| Q4 2025 | 6 |
| Q3 2025 | 8 |
| Q2 2025 | 9 |
| Q1 2025 | 11 |
| Q4 2024 | 8 |
| Q3 2024 | 10 |
Questions about Evolus
Which superinvestors own Evolus?
6 of the superinvestors we track hold Evolus (EOLS) in their latest 13F filings, $55M in total. Wilmot Harkey, Steve Cohen, David Shaw, Jim Simons, Cliff Asness, Paul Tudor Jones.
Who is the largest superinvestor holder of EOLS?
The largest holder is Wilmot Harkey (Nantahala Capital Management), with $39M, 2.4% of the portfolio.
From Evolus's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.